These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 39334524)

  • 21. Identification of RBM46 as a novel APOBEC1 cofactor for C-to-U RNA-editing activity.
    Wang S; Kim K; Gelvez N; Chung C; Gout JF; Fixman B; Vermulst M; Chen XS
    J Mol Biol; 2023 Dec; 435(24):. PubMed ID: 38708190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits.
    Greeve J; Jona VK; Chowdhury NR; Horwitz MS; Chowdhury JR
    J Lipid Res; 1996 Sep; 37(9):2001-17. PubMed ID: 8895066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apobec-1 and apolipoprotein B mRNA editing.
    Chan L; Chang BH; Nakamuta M; Li WH; Smith LC
    Biochim Biophys Acta; 1997 Mar; 1345(1):11-26. PubMed ID: 9084497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A1CF Binding to the p65 Interaction Site on NKRF Decreased IFN-β Expression and p65 Phosphorylation (Ser536) in Renal Carcinoma Cells.
    Liu Y; Yang J; Weng D; Xie Y
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1.
    Yang Y; Sowden MP; Smith HC
    J Biol Chem; 2000 Jul; 275(30):22663-9. PubMed ID: 10833526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
    Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
    J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic Acid editing in a murine model of congenital hypothyroidism.
    Mukhopadhyay D; Plateroti M; Anant S; Nassir F; Samarut J; Davidson NO
    Endocrinology; 2003 Feb; 144(2):711-9. PubMed ID: 12538634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
    Chester A; Scott J; Anant S; Navaratnam N
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing.
    Lau PP; Zhu HJ; Nakamuta M; Chan L
    J Biol Chem; 1997 Jan; 272(3):1452-5. PubMed ID: 8999813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
    Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
    J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity.
    Blanc V; Henderson JO; Kennedy S; Davidson NO
    J Biol Chem; 2001 Dec; 276(49):46386-93. PubMed ID: 11571303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing.
    Fossat N; Tam PP
    RNA Biol; 2014; 11(10):1233-7. PubMed ID: 25585043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.
    Chen Z; Eggerman TL; Patterson AP
    Biochem J; 2001 Aug; 357(Pt 3):661-72. PubMed ID: 11463337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
    Mukhopadhyay D; Anant S; Lee RM; Kennedy S; Viskochil D; Davidson NO
    Am J Hum Genet; 2002 Jan; 70(1):38-50. PubMed ID: 11727199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality.
    Blanc V; Henderson JO; Newberry EP; Kennedy S; Luo J; Davidson NO
    Mol Cell Biol; 2005 Aug; 25(16):7260-9. PubMed ID: 16055734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
    Siddiqui JF; Van Mater D; Sowden MP; Smith HC
    Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
    Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
    Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex.
    Lellek H; Kirsten R; Diehl I; Apostel F; Buck F; Greeve J
    J Biol Chem; 2000 Jun; 275(26):19848-56. PubMed ID: 10781591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors.
    Sowden MP; Ballatori N; Jensen KL; Reed LH; Smith HC
    J Cell Sci; 2002 Mar; 115(Pt 5):1027-39. PubMed ID: 11870221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.